nodes	percent_of_prediction	percent_of_DWPC	metapath
Celecoxib—PTGS2—metabolic syndrome X	0.349	0.529	CbGaD
Celecoxib—ALB—metabolic syndrome X	0.311	0.471	CbGaD
Celecoxib—Angina unstable—Metformin—metabolic syndrome X	0.00691	0.111	CcSEcCtD
Celecoxib—MAPK14—blood vessel—metabolic syndrome X	0.00544	0.0965	CbGeAlD
Celecoxib—PDPK1—kidney—metabolic syndrome X	0.00444	0.0787	CbGeAlD
Celecoxib—PDPK1—adipose tissue—metabolic syndrome X	0.004	0.071	CbGeAlD
Celecoxib—PDPK1—liver—metabolic syndrome X	0.00281	0.0498	CbGeAlD
Celecoxib—Nail disorder—Metformin—metabolic syndrome X	0.00269	0.0431	CcSEcCtD
Celecoxib—CA5A—liver—metabolic syndrome X	0.00264	0.0467	CbGeAlD
Celecoxib—MAPK14—cardiovascular system—metabolic syndrome X	0.00243	0.043	CbGeAlD
Celecoxib—MAPK14—kidney—metabolic syndrome X	0.00237	0.0421	CbGeAlD
Celecoxib—Fungal infection—Metformin—metabolic syndrome X	0.00226	0.0362	CcSEcCtD
Celecoxib—MAPK14—adipose tissue—metabolic syndrome X	0.00214	0.038	CbGeAlD
Celecoxib—PTGS2—artery—metabolic syndrome X	0.00201	0.0356	CbGeAlD
Celecoxib—CA12—kidney—metabolic syndrome X	0.0018	0.032	CbGeAlD
Celecoxib—PTGS2—endothelium—metabolic syndrome X	0.0017	0.0301	CbGeAlD
Celecoxib—CA5B—cardiovascular system—metabolic syndrome X	0.00165	0.0293	CbGeAlD
Celecoxib—Neuropathy—Metformin—metabolic syndrome X	0.00164	0.0262	CcSEcCtD
Celecoxib—PTGS2—blood vessel—metabolic syndrome X	0.00156	0.0277	CbGeAlD
Celecoxib—Etoricoxib—PTGS2—metabolic syndrome X	0.00154	1	CrCbGaD
Celecoxib—MAPK14—liver—metabolic syndrome X	0.0015	0.0266	CbGeAlD
Celecoxib—Ear pain—Metformin—metabolic syndrome X	0.00148	0.0238	CcSEcCtD
Celecoxib—CA14—liver—metabolic syndrome X	0.00146	0.0259	CbGeAlD
Celecoxib—CA5B—adipose tissue—metabolic syndrome X	0.00146	0.0258	CbGeAlD
Celecoxib—Hypoglycaemia—Metformin—metabolic syndrome X	0.0013	0.0208	CcSEcCtD
Celecoxib—Migraine—Metformin—metabolic syndrome X	0.00125	0.02	CcSEcCtD
Celecoxib—ABCC4—kidney—metabolic syndrome X	0.00121	0.0215	CbGeAlD
Celecoxib—Liver function test abnormal—Metformin—metabolic syndrome X	0.00117	0.0187	CcSEcCtD
Celecoxib—Abdominal pain upper—Metformin—metabolic syndrome X	0.00116	0.0185	CcSEcCtD
Celecoxib—Breast disorder—Metformin—metabolic syndrome X	0.00114	0.0183	CcSEcCtD
Celecoxib—CA4—cardiovascular system—metabolic syndrome X	0.00114	0.0202	CbGeAlD
Celecoxib—Nasopharyngitis—Metformin—metabolic syndrome X	0.00113	0.0181	CcSEcCtD
Celecoxib—CA4—kidney—metabolic syndrome X	0.00112	0.0198	CbGeAlD
Celecoxib—ABCC4—adipose tissue—metabolic syndrome X	0.00109	0.0194	CbGeAlD
Celecoxib—Pancreatitis—Metformin—metabolic syndrome X	0.00107	0.0172	CcSEcCtD
Celecoxib—Angina pectoris—Metformin—metabolic syndrome X	0.00107	0.0171	CcSEcCtD
Celecoxib—Sweating increased—Metformin—metabolic syndrome X	0.00107	0.0171	CcSEcCtD
Celecoxib—Upper respiratory tract infection—Metformin—metabolic syndrome X	0.00102	0.0163	CcSEcCtD
Celecoxib—CA4—adipose tissue—metabolic syndrome X	0.00101	0.0178	CbGeAlD
Celecoxib—Infestation—Metformin—metabolic syndrome X	0.000976	0.0156	CcSEcCtD
Celecoxib—Infestation NOS—Metformin—metabolic syndrome X	0.000976	0.0156	CcSEcCtD
Celecoxib—Neuropathy peripheral—Metformin—metabolic syndrome X	0.000957	0.0153	CcSEcCtD
Celecoxib—CA2—cardiovascular system—metabolic syndrome X	0.000945	0.0168	CbGeAlD
Celecoxib—CA2—kidney—metabolic syndrome X	0.000925	0.0164	CbGeAlD
Celecoxib—Hepatobiliary disease—Metformin—metabolic syndrome X	0.000923	0.0148	CcSEcCtD
Celecoxib—ORM1—liver—metabolic syndrome X	0.000904	0.016	CbGeAlD
Celecoxib—Rhinitis—Metformin—metabolic syndrome X	0.000879	0.0141	CcSEcCtD
Celecoxib—Hepatitis—Metformin—metabolic syndrome X	0.000876	0.014	CcSEcCtD
Celecoxib—Hypoaesthesia—Metformin—metabolic syndrome X	0.000872	0.014	CcSEcCtD
Celecoxib—Oedema peripheral—Metformin—metabolic syndrome X	0.000863	0.0138	CcSEcCtD
Celecoxib—Connective tissue disorder—Metformin—metabolic syndrome X	0.000861	0.0138	CcSEcCtD
Celecoxib—CA2—adipose tissue—metabolic syndrome X	0.000834	0.0148	CbGeAlD
Celecoxib—Eye disorder—Metformin—metabolic syndrome X	0.000819	0.0131	CcSEcCtD
Celecoxib—Flushing—Metformin—metabolic syndrome X	0.000813	0.013	CcSEcCtD
Celecoxib—Cardiac disorder—Metformin—metabolic syndrome X	0.000813	0.013	CcSEcCtD
Celecoxib—CYP2C9—cardiovascular system—metabolic syndrome X	0.0008	0.0142	CbGeAlD
Celecoxib—Angiopathy—Metformin—metabolic syndrome X	0.000795	0.0127	CcSEcCtD
Celecoxib—ALB—liver—metabolic syndrome X	0.000792	0.0141	CbGeAlD
Celecoxib—Immune system disorder—Metformin—metabolic syndrome X	0.000792	0.0127	CcSEcCtD
Celecoxib—Mediastinal disorder—Metformin—metabolic syndrome X	0.00079	0.0127	CcSEcCtD
Celecoxib—ABCC4—liver—metabolic syndrome X	0.000767	0.0136	CbGeAlD
Celecoxib—Flatulence—Metformin—metabolic syndrome X	0.000752	0.012	CcSEcCtD
Celecoxib—Dysgeusia—Metformin—metabolic syndrome X	0.000747	0.012	CcSEcCtD
Celecoxib—Muscle spasms—Metformin—metabolic syndrome X	0.000734	0.0117	CcSEcCtD
Celecoxib—Vision blurred—Metformin—metabolic syndrome X	0.000719	0.0115	CcSEcCtD
Celecoxib—PTGS2—cardiovascular system—metabolic syndrome X	0.000698	0.0124	CbGeAlD
Celecoxib—Syncope—Metformin—metabolic syndrome X	0.000684	0.011	CcSEcCtD
Celecoxib—PTGS2—kidney—metabolic syndrome X	0.000683	0.0121	CbGeAlD
Celecoxib—Palpitations—Metformin—metabolic syndrome X	0.000674	0.0108	CcSEcCtD
Celecoxib—Loss of consciousness—Metformin—metabolic syndrome X	0.000671	0.0107	CcSEcCtD
Celecoxib—Hypertension—Metformin—metabolic syndrome X	0.000659	0.0106	CcSEcCtD
Celecoxib—Chest pain—Metformin—metabolic syndrome X	0.00065	0.0104	CcSEcCtD
Celecoxib—Myalgia—Metformin—metabolic syndrome X	0.00065	0.0104	CcSEcCtD
Celecoxib—Unspecified disorder of skin and subcutaneous tissue—Metformin—metabolic syndrome X	0.000645	0.0103	CcSEcCtD
Celecoxib—Oedema—Metformin—metabolic syndrome X	0.000623	0.00997	CcSEcCtD
Celecoxib—Infection—Metformin—metabolic syndrome X	0.000619	0.00991	CcSEcCtD
Celecoxib—PTGS2—adipose tissue—metabolic syndrome X	0.000616	0.0109	CbGeAlD
Celecoxib—Shock—Metformin—metabolic syndrome X	0.000613	0.00981	CcSEcCtD
Celecoxib—Nervous system disorder—Metformin—metabolic syndrome X	0.000611	0.00978	CcSEcCtD
Celecoxib—Thrombocytopenia—Metformin—metabolic syndrome X	0.00061	0.00977	CcSEcCtD
Celecoxib—Skin disorder—Metformin—metabolic syndrome X	0.000605	0.00969	CcSEcCtD
Celecoxib—Hyperhidrosis—Metformin—metabolic syndrome X	0.000602	0.00964	CcSEcCtD
Celecoxib—CYP3A4—kidney—metabolic syndrome X	0.000597	0.0106	CbGeAlD
Celecoxib—Anorexia—Metformin—metabolic syndrome X	0.000594	0.00951	CcSEcCtD
Celecoxib—CYP2D6—kidney—metabolic syndrome X	0.000587	0.0104	CbGeAlD
Celecoxib—CA2—liver—metabolic syndrome X	0.000585	0.0104	CbGeAlD
Celecoxib—Musculoskeletal discomfort—Metformin—metabolic syndrome X	0.000567	0.00909	CcSEcCtD
Celecoxib—Paraesthesia—Metformin—metabolic syndrome X	0.000559	0.00896	CcSEcCtD
Celecoxib—Dyspnoea—Metformin—metabolic syndrome X	0.000555	0.00889	CcSEcCtD
Celecoxib—Somnolence—Metformin—metabolic syndrome X	0.000554	0.00887	CcSEcCtD
Celecoxib—Dyspepsia—Metformin—metabolic syndrome X	0.000548	0.00878	CcSEcCtD
Celecoxib—Decreased appetite—Metformin—metabolic syndrome X	0.000541	0.00867	CcSEcCtD
Celecoxib—Gastrointestinal disorder—Metformin—metabolic syndrome X	0.000538	0.00861	CcSEcCtD
Celecoxib—Fatigue—Metformin—metabolic syndrome X	0.000537	0.0086	CcSEcCtD
Celecoxib—Constipation—Metformin—metabolic syndrome X	0.000532	0.00853	CcSEcCtD
Celecoxib—Feeling abnormal—Metformin—metabolic syndrome X	0.000513	0.00822	CcSEcCtD
Celecoxib—Gastrointestinal pain—Metformin—metabolic syndrome X	0.000509	0.00816	CcSEcCtD
Celecoxib—Urticaria—Metformin—metabolic syndrome X	0.000495	0.00792	CcSEcCtD
Celecoxib—CYP2C9—liver—metabolic syndrome X	0.000495	0.00877	CbGeAlD
Celecoxib—Abdominal pain—Metformin—metabolic syndrome X	0.000492	0.00788	CcSEcCtD
Celecoxib—Asthenia—Metformin—metabolic syndrome X	0.000447	0.00716	CcSEcCtD
Celecoxib—Pruritus—Metformin—metabolic syndrome X	0.000441	0.00706	CcSEcCtD
Celecoxib—PTGS2—liver—metabolic syndrome X	0.000432	0.00766	CbGeAlD
Celecoxib—Diarrhoea—Metformin—metabolic syndrome X	0.000426	0.00682	CcSEcCtD
Celecoxib—Dizziness—Metformin—metabolic syndrome X	0.000412	0.0066	CcSEcCtD
Celecoxib—Vomiting—Metformin—metabolic syndrome X	0.000396	0.00634	CcSEcCtD
Celecoxib—Rash—Metformin—metabolic syndrome X	0.000393	0.00629	CcSEcCtD
Celecoxib—Dermatitis—Metformin—metabolic syndrome X	0.000392	0.00628	CcSEcCtD
Celecoxib—Headache—Metformin—metabolic syndrome X	0.00039	0.00625	CcSEcCtD
Celecoxib—CYP3A4—liver—metabolic syndrome X	0.000377	0.00669	CbGeAlD
Celecoxib—CYP2D6—liver—metabolic syndrome X	0.000371	0.00658	CbGeAlD
Celecoxib—Nausea—Metformin—metabolic syndrome X	0.00037	0.00592	CcSEcCtD
Celecoxib—MAPK14—Hemostasis—TGFB1—metabolic syndrome X	2.23e-05	0.000102	CbGpPWpGaD
Celecoxib—ALB—Metabolism—APOA5—metabolic syndrome X	2.22e-05	0.000101	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—NOS3—metabolic syndrome X	2.2e-05	0.0001	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism—CETP—metabolic syndrome X	2.2e-05	0.0001	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—FMO3—metabolic syndrome X	2.18e-05	9.95e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism of lipids and lipoproteins—APOB—metabolic syndrome X	2.16e-05	9.87e-05	CbGpPWpGaD
Celecoxib—ALB—Metabolism of lipids and lipoproteins—AGT—metabolic syndrome X	2.16e-05	9.85e-05	CbGpPWpGaD
Celecoxib—PTGS2—Integrated Pancreatic Cancer Pathway—AKT1—metabolic syndrome X	2.16e-05	9.84e-05	CbGpPWpGaD
Celecoxib—MAPK14—Developmental Biology—TNF—metabolic syndrome X	2.12e-05	9.68e-05	CbGpPWpGaD
Celecoxib—ALB—Transmembrane transport of small molecules—PPARA—metabolic syndrome X	2.12e-05	9.67e-05	CbGpPWpGaD
Celecoxib—ALB—Metabolism of lipids and lipoproteins—APOE—metabolic syndrome X	2.12e-05	9.66e-05	CbGpPWpGaD
Celecoxib—PTGS2—Disease—SLC2A4—metabolic syndrome X	2.11e-05	9.65e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism of lipids and lipoproteins—PLA2G4A—metabolic syndrome X	2.11e-05	9.61e-05	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism—SCARB1—metabolic syndrome X	2.1e-05	9.6e-05	CbGpPWpGaD
Celecoxib—MAPK14—Immune System—IRS1—metabolic syndrome X	2.1e-05	9.6e-05	CbGpPWpGaD
Celecoxib—ALB—Metabolism of lipids and lipoproteins—APOA1—metabolic syndrome X	2.09e-05	9.54e-05	CbGpPWpGaD
Celecoxib—PDPK1—Disease—TGFB1—metabolic syndrome X	2.08e-05	9.47e-05	CbGpPWpGaD
Celecoxib—CA9—Metabolism—PTGS2—metabolic syndrome X	2.07e-05	9.45e-05	CbGpPWpGaD
Celecoxib—ALB—Metabolism—TRIB3—metabolic syndrome X	2.07e-05	9.43e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism of lipids and lipoproteins—LPL—metabolic syndrome X	2.07e-05	9.43e-05	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism of lipids and lipoproteins—ALB—metabolic syndrome X	2.05e-05	9.35e-05	CbGpPWpGaD
Celecoxib—PTGS2—Disease—GOT1—metabolic syndrome X	2.05e-05	9.34e-05	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism—SREBF1—metabolic syndrome X	2.04e-05	9.32e-05	CbGpPWpGaD
Celecoxib—MAPK14—Gene Expression—PPARG—metabolic syndrome X	2.04e-05	9.32e-05	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—G6PD—metabolic syndrome X	2.01e-05	9.16e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—G6PD—metabolic syndrome X	1.99e-05	9.08e-05	CbGpPWpGaD
Celecoxib—ALB—Transmembrane transport of small molecules—APOA1—metabolic syndrome X	1.99e-05	9.08e-05	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism—HMGCR—metabolic syndrome X	1.99e-05	9.07e-05	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism—GOT2—metabolic syndrome X	1.99e-05	9.07e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism of lipids and lipoproteins—CD36—metabolic syndrome X	1.96e-05	8.96e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—IGF2—metabolic syndrome X	1.96e-05	8.95e-05	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—HDAC3—metabolic syndrome X	1.96e-05	8.94e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—EPHX2—metabolic syndrome X	1.94e-05	8.86e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—MLXIPL—metabolic syndrome X	1.94e-05	8.86e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—HDAC3—metabolic syndrome X	1.94e-05	8.86e-05	CbGpPWpGaD
Celecoxib—ALB—Hemostasis—IGF1—metabolic syndrome X	1.92e-05	8.76e-05	CbGpPWpGaD
Celecoxib—CA14—Metabolism—AKT1—metabolic syndrome X	1.92e-05	8.74e-05	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—GCKR—metabolic syndrome X	1.91e-05	8.74e-05	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—LPA—metabolic syndrome X	1.91e-05	8.74e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—APOB—metabolic syndrome X	1.9e-05	8.69e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—GCKR—metabolic syndrome X	1.9e-05	8.66e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—LPA—metabolic syndrome X	1.9e-05	8.66e-05	CbGpPWpGaD
Celecoxib—PDPK1—GPCR downstream signaling—AKT1—metabolic syndrome X	1.88e-05	8.59e-05	CbGpPWpGaD
Celecoxib—CA5A—Metabolism—AKT1—metabolic syndrome X	1.87e-05	8.52e-05	CbGpPWpGaD
Celecoxib—CA6—Metabolism—AKT1—metabolic syndrome X	1.87e-05	8.52e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—CCL5—metabolic syndrome X	1.86e-05	8.49e-05	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—PLA2G6—metabolic syndrome X	1.85e-05	8.46e-05	CbGpPWpGaD
Celecoxib—ALB—Metabolism—NAMPT—metabolic syndrome X	1.85e-05	8.46e-05	CbGpPWpGaD
Celecoxib—PDPK1—Signaling by GPCR—IL6—metabolic syndrome X	1.85e-05	8.46e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—PLA2G4A—metabolic syndrome X	1.85e-05	8.45e-05	CbGpPWpGaD
Celecoxib—ALB—Metabolism of lipids and lipoproteins—PPARG—metabolic syndrome X	1.84e-05	8.41e-05	CbGpPWpGaD
Celecoxib—ALB—Metabolism—LIPC—metabolic syndrome X	1.84e-05	8.41e-05	CbGpPWpGaD
Celecoxib—ALB—Metabolism—GCK—metabolic syndrome X	1.84e-05	8.41e-05	CbGpPWpGaD
Celecoxib—MAPK14—Gene Expression—SERPINE1—metabolic syndrome X	1.84e-05	8.4e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—PLA2G6—metabolic syndrome X	1.84e-05	8.39e-05	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—APOA5—metabolic syndrome X	1.84e-05	8.38e-05	CbGpPWpGaD
Celecoxib—ALB—Metabolism—APOC3—metabolic syndrome X	1.83e-05	8.35e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—G6PC2—metabolic syndrome X	1.83e-05	8.33e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism of lipids and lipoproteins—PPARA—metabolic syndrome X	1.83e-05	8.33e-05	CbGpPWpGaD
Celecoxib—ALB—Hemostasis—SERPINE1—metabolic syndrome X	1.82e-05	8.32e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—APOA5—metabolic syndrome X	1.82e-05	8.3e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—LPL—metabolic syndrome X	1.82e-05	8.3e-05	CbGpPWpGaD
Celecoxib—ALB—Metabolism—CETP—metabolic syndrome X	1.78e-05	8.11e-05	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism—ABCA1—metabolic syndrome X	1.77e-05	8.08e-05	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism—SLC2A4—metabolic syndrome X	1.77e-05	8.08e-05	CbGpPWpGaD
Celecoxib—ABCC4—Hemostasis—AKT1—metabolic syndrome X	1.77e-05	8.07e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism of lipids and lipoproteins—AGT—metabolic syndrome X	1.77e-05	8.07e-05	CbGpPWpGaD
Celecoxib—CA5B—Metabolism—AKT1—metabolic syndrome X	1.74e-05	7.95e-05	CbGpPWpGaD
Celecoxib—ALB—Hemostasis—NOS3—metabolic syndrome X	1.74e-05	7.95e-05	CbGpPWpGaD
Celecoxib—PTGS2—Disease—APOB—metabolic syndrome X	1.74e-05	7.93e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism of lipids and lipoproteins—APOE—metabolic syndrome X	1.73e-05	7.9e-05	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism—GOT1—metabolic syndrome X	1.72e-05	7.83e-05	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism—GGT1—metabolic syndrome X	1.72e-05	7.83e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism of lipids and lipoproteins—APOA1—metabolic syndrome X	1.71e-05	7.81e-05	CbGpPWpGaD
Celecoxib—MAPK14—Developmental Biology—IL6—metabolic syndrome X	1.71e-05	7.81e-05	CbGpPWpGaD
Celecoxib—PDPK1—Signaling by GPCR—AKT1—metabolic syndrome X	1.71e-05	7.8e-05	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—TRIB3—metabolic syndrome X	1.71e-05	7.79e-05	CbGpPWpGaD
Celecoxib—ALB—Metabolism—SCARB1—metabolic syndrome X	1.7e-05	7.77e-05	CbGpPWpGaD
Celecoxib—PDPK1—Immune System—IL6—metabolic syndrome X	1.69e-05	7.73e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—TRIB3—metabolic syndrome X	1.69e-05	7.72e-05	CbGpPWpGaD
Celecoxib—PTGS2—Disease—LPL—metabolic syndrome X	1.66e-05	7.57e-05	CbGpPWpGaD
Celecoxib—ALB—Metabolism—SREBF1—metabolic syndrome X	1.65e-05	7.54e-05	CbGpPWpGaD
Celecoxib—CA12—Metabolism—AKT1—metabolic syndrome X	1.61e-05	7.37e-05	CbGpPWpGaD
Celecoxib—ALB—Metabolism—HMGCR—metabolic syndrome X	1.61e-05	7.33e-05	CbGpPWpGaD
Celecoxib—ALB—Metabolism—GOT2—metabolic syndrome X	1.61e-05	7.33e-05	CbGpPWpGaD
Celecoxib—MAPK14—Developmental Biology—AKT1—metabolic syndrome X	1.58e-05	7.2e-05	CbGpPWpGaD
Celecoxib—PDPK1—Disease—IL6—metabolic syndrome X	1.56e-05	7.14e-05	CbGpPWpGaD
Celecoxib—PDPK1—Immune System—AKT1—metabolic syndrome X	1.56e-05	7.13e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—AGT—metabolic syndrome X	1.56e-05	7.1e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—FABP4—metabolic syndrome X	1.55e-05	7.09e-05	CbGpPWpGaD
Celecoxib—ALB—Platelet activation, signaling and aggregation—AKT1—metabolic syndrome X	1.55e-05	7.09e-05	CbGpPWpGaD
Celecoxib—MAPK14—Hemostasis—AKT1—metabolic syndrome X	1.55e-05	7.07e-05	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—NAMPT—metabolic syndrome X	1.53e-05	6.98e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—APOE—metabolic syndrome X	1.52e-05	6.96e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—LEP—metabolic syndrome X	1.52e-05	6.96e-05	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—GCK—metabolic syndrome X	1.52e-05	6.94e-05	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—LIPC—metabolic syndrome X	1.52e-05	6.94e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—NAMPT—metabolic syndrome X	1.52e-05	6.92e-05	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—APOC3—metabolic syndrome X	1.51e-05	6.9e-05	CbGpPWpGaD
Celecoxib—MAPK14—Innate Immune System—IL6—metabolic syndrome X	1.51e-05	6.9e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—metabolic syndrome X	1.51e-05	6.88e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—LIPC—metabolic syndrome X	1.51e-05	6.88e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—GCK—metabolic syndrome X	1.51e-05	6.88e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—APOA1—metabolic syndrome X	1.51e-05	6.88e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—APOC3—metabolic syndrome X	1.5e-05	6.84e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—HSD11B1—metabolic syndrome X	1.47e-05	6.72e-05	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—CETP—metabolic syndrome X	1.47e-05	6.7e-05	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism—APOB—metabolic syndrome X	1.46e-05	6.64e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—CETP—metabolic syndrome X	1.45e-05	6.64e-05	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—TGFB1—metabolic syndrome X	1.45e-05	6.63e-05	CbGpPWpGaD
Celecoxib—ALB—Metabolism of lipids and lipoproteins—PTGS2—metabolic syndrome X	1.45e-05	6.62e-05	CbGpPWpGaD
Celecoxib—PDPK1—Disease—AKT1—metabolic syndrome X	1.44e-05	6.58e-05	CbGpPWpGaD
Celecoxib—ALB—Metabolism—SLC2A4—metabolic syndrome X	1.43e-05	6.54e-05	CbGpPWpGaD
Celecoxib—ALB—Metabolism—ABCA1—metabolic syndrome X	1.43e-05	6.54e-05	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism—PLA2G4A—metabolic syndrome X	1.42e-05	6.46e-05	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—SCARB1—metabolic syndrome X	1.41e-05	6.41e-05	CbGpPWpGaD
Celecoxib—MAPK14—Innate Immune System—AKT1—metabolic syndrome X	1.39e-05	6.36e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—SCARB1—metabolic syndrome X	1.39e-05	6.36e-05	CbGpPWpGaD
Celecoxib—PTGS2—Disease—APOE—metabolic syndrome X	1.39e-05	6.35e-05	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism—LPL—metabolic syndrome X	1.39e-05	6.34e-05	CbGpPWpGaD
Celecoxib—ALB—Metabolism—GGT1—metabolic syndrome X	1.39e-05	6.33e-05	CbGpPWpGaD
Celecoxib—ALB—Metabolism—GOT1—metabolic syndrome X	1.39e-05	6.33e-05	CbGpPWpGaD
Celecoxib—PTGS2—Disease—APOA1—metabolic syndrome X	1.37e-05	6.27e-05	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—SREBF1—metabolic syndrome X	1.36e-05	6.23e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—IRS1—metabolic syndrome X	1.36e-05	6.21e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism of lipids and lipoproteins—ALB—metabolic syndrome X	1.36e-05	6.19e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—SREBF1—metabolic syndrome X	1.35e-05	6.17e-05	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—HMGCR—metabolic syndrome X	1.33e-05	6.06e-05	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—GOT2—metabolic syndrome X	1.33e-05	6.06e-05	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism—CD36—metabolic syndrome X	1.32e-05	6.02e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—HMGCR—metabolic syndrome X	1.32e-05	6e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—GOT2—metabolic syndrome X	1.32e-05	6e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—G6PD—metabolic syndrome X	1.31e-05	5.99e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—INS—metabolic syndrome X	1.3e-05	5.94e-05	CbGpPWpGaD
Celecoxib—CA4—Metabolism—AKT1—metabolic syndrome X	1.29e-05	5.88e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—CCL2—metabolic syndrome X	1.28e-05	5.85e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—HDAC3—metabolic syndrome X	1.28e-05	5.84e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—IGF1—metabolic syndrome X	1.26e-05	5.75e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—GCKR—metabolic syndrome X	1.25e-05	5.71e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—LPA—metabolic syndrome X	1.25e-05	5.71e-05	CbGpPWpGaD
Celecoxib—PTGS2—Disease—IRS1—metabolic syndrome X	1.24e-05	5.66e-05	CbGpPWpGaD
Celecoxib—CA2—Metabolism—AKT1—metabolic syndrome X	1.23e-05	5.63e-05	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism—PPARA—metabolic syndrome X	1.23e-05	5.6e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—PLA2G6—metabolic syndrome X	1.21e-05	5.53e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—APOA5—metabolic syndrome X	1.2e-05	5.48e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—SERPINE1—metabolic syndrome X	1.2e-05	5.46e-05	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism—AGT—metabolic syndrome X	1.19e-05	5.42e-05	CbGpPWpGaD
Celecoxib—PTGS2—Disease—INS—metabolic syndrome X	1.19e-05	5.42e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—metabolic syndrome X	1.19e-05	5.42e-05	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—ABCA1—metabolic syndrome X	1.18e-05	5.4e-05	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—SLC2A4—metabolic syndrome X	1.18e-05	5.4e-05	CbGpPWpGaD
Celecoxib—ALB—Metabolism—APOB—metabolic syndrome X	1.18e-05	5.37e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—ABCA1—metabolic syndrome X	1.17e-05	5.35e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—SLC2A4—metabolic syndrome X	1.17e-05	5.35e-05	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism—APOE—metabolic syndrome X	1.16e-05	5.31e-05	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism—APOA1—metabolic syndrome X	1.15e-05	5.25e-05	CbGpPWpGaD
Celecoxib—ALB—Hemostasis—TGFB1—metabolic syndrome X	1.15e-05	5.25e-05	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—GGT1—metabolic syndrome X	1.15e-05	5.23e-05	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—GOT1—metabolic syndrome X	1.15e-05	5.23e-05	CbGpPWpGaD
Celecoxib—ALB—Metabolism—PLA2G4A—metabolic syndrome X	1.15e-05	5.23e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—NOS3—metabolic syndrome X	1.14e-05	5.21e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—GGT1—metabolic syndrome X	1.14e-05	5.18e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—GOT1—metabolic syndrome X	1.14e-05	5.18e-05	CbGpPWpGaD
Celecoxib—ALB—Metabolism—LPL—metabolic syndrome X	1.12e-05	5.13e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—TRIB3—metabolic syndrome X	1.12e-05	5.09e-05	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—IL6—metabolic syndrome X	1.1e-05	5e-05	CbGpPWpGaD
Celecoxib—PTGS2—Disease—SERPINE1—metabolic syndrome X	1.09e-05	4.98e-05	CbGpPWpGaD
Celecoxib—ALB—Metabolism—CD36—metabolic syndrome X	1.07e-05	4.87e-05	CbGpPWpGaD
Celecoxib—PTGS2—Disease—NOS3—metabolic syndrome X	1.04e-05	4.75e-05	CbGpPWpGaD
Celecoxib—CA9—Metabolism—AKT1—metabolic syndrome X	1.04e-05	4.75e-05	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism—PPARG—metabolic syndrome X	1.01e-05	4.63e-05	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—AKT1—metabolic syndrome X	1.01e-05	4.61e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—NAMPT—metabolic syndrome X	1e-05	4.57e-05	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism—INS—metabolic syndrome X	9.95e-06	4.54e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—LIPC—metabolic syndrome X	9.95e-06	4.54e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—GCK—metabolic syndrome X	9.95e-06	4.54e-05	CbGpPWpGaD
Celecoxib—ALB—Metabolism—PPARA—metabolic syndrome X	9.93e-06	4.53e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—APOC3—metabolic syndrome X	9.88e-06	4.51e-05	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—APOB—metabolic syndrome X	9.72e-06	4.44e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—APOB—metabolic syndrome X	9.64e-06	4.4e-05	CbGpPWpGaD
Celecoxib—ALB—Metabolism—AGT—metabolic syndrome X	9.62e-06	4.39e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—CETP—metabolic syndrome X	9.6e-06	4.38e-05	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—PLA2G4A—metabolic syndrome X	9.46e-06	4.31e-05	CbGpPWpGaD
Celecoxib—ALB—Metabolism—APOE—metabolic syndrome X	9.42e-06	4.3e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—PLA2G4A—metabolic syndrome X	9.38e-06	4.28e-05	CbGpPWpGaD
Celecoxib—ALB—Metabolism—APOA1—metabolic syndrome X	9.32e-06	4.25e-05	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—LPL—metabolic syndrome X	9.28e-06	4.24e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—LPL—metabolic syndrome X	9.2e-06	4.2e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—SCARB1—metabolic syndrome X	9.19e-06	4.19e-05	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism—ALB—metabolic syndrome X	9.12e-06	4.16e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—SREBF1—metabolic syndrome X	8.92e-06	4.07e-05	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—CD36—metabolic syndrome X	8.82e-06	4.02e-05	CbGpPWpGaD
Celecoxib—MAPK14—Immune System—IL6—metabolic syndrome X	8.8e-06	4.02e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—CD36—metabolic syndrome X	8.74e-06	3.99e-05	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism—NOS3—metabolic syndrome X	8.73e-06	3.98e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—HMGCR—metabolic syndrome X	8.68e-06	3.96e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—GOT2—metabolic syndrome X	8.68e-06	3.96e-05	CbGpPWpGaD
Celecoxib—ALB—Metabolism—PPARG—metabolic syndrome X	8.21e-06	3.75e-05	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—PPARA—metabolic syndrome X	8.2e-06	3.74e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—PPARA—metabolic syndrome X	8.13e-06	3.71e-05	CbGpPWpGaD
Celecoxib—MAPK14—Immune System—AKT1—metabolic syndrome X	8.12e-06	3.71e-05	CbGpPWpGaD
Celecoxib—MAPK14—Gene Expression—AKT1—metabolic syndrome X	8.08e-06	3.68e-05	CbGpPWpGaD
Celecoxib—ALB—Metabolism—INS—metabolic syndrome X	8.05e-06	3.67e-05	CbGpPWpGaD
Celecoxib—ALB—Hemostasis—AKT1—metabolic syndrome X	8e-06	3.65e-05	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—AGT—metabolic syndrome X	7.94e-06	3.62e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—AGT—metabolic syndrome X	7.87e-06	3.59e-05	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—APOE—metabolic syndrome X	7.78e-06	3.55e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—ABCA1—metabolic syndrome X	7.73e-06	3.53e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—SLC2A4—metabolic syndrome X	7.73e-06	3.53e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—APOE—metabolic syndrome X	7.71e-06	3.52e-05	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—APOA1—metabolic syndrome X	7.69e-06	3.51e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—APOA1—metabolic syndrome X	7.63e-06	3.48e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—TGFB1—metabolic syndrome X	7.55e-06	3.45e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—GOT1—metabolic syndrome X	7.49e-06	3.42e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—GGT1—metabolic syndrome X	7.49e-06	3.42e-05	CbGpPWpGaD
Celecoxib—ALB—Metabolism—NOS3—metabolic syndrome X	7.06e-06	3.22e-05	CbGpPWpGaD
Celecoxib—PTGS2—Disease—TGFB1—metabolic syndrome X	6.89e-06	3.14e-05	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—PPARG—metabolic syndrome X	6.78e-06	3.09e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—PPARG—metabolic syndrome X	6.72e-06	3.07e-05	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—INS—metabolic syndrome X	6.65e-06	3.03e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—INS—metabolic syndrome X	6.59e-06	3.01e-05	CbGpPWpGaD
Celecoxib—ALB—Metabolism—PTGS2—metabolic syndrome X	6.46e-06	2.95e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—APOB—metabolic syndrome X	6.36e-06	2.9e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—PLA2G4A—metabolic syndrome X	6.18e-06	2.82e-05	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—ALB—metabolic syndrome X	6.09e-06	2.78e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—LPL—metabolic syndrome X	6.07e-06	2.77e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—ALB—metabolic syndrome X	6.04e-06	2.76e-05	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—NOS3—metabolic syndrome X	5.83e-06	2.66e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—NOS3—metabolic syndrome X	5.78e-06	2.64e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—CD36—metabolic syndrome X	5.77e-06	2.63e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—IL6—metabolic syndrome X	5.69e-06	2.6e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—PPARA—metabolic syndrome X	5.36e-06	2.45e-05	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—PTGS2—metabolic syndrome X	5.33e-06	2.43e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—PTGS2—metabolic syndrome X	5.29e-06	2.41e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—AKT1—metabolic syndrome X	5.25e-06	2.4e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—AGT—metabolic syndrome X	5.19e-06	2.37e-05	CbGpPWpGaD
Celecoxib—PTGS2—Disease—IL6—metabolic syndrome X	5.19e-06	2.37e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—APOE—metabolic syndrome X	5.09e-06	2.32e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—APOA1—metabolic syndrome X	5.03e-06	2.29e-05	CbGpPWpGaD
Celecoxib—PTGS2—Disease—AKT1—metabolic syndrome X	4.79e-06	2.19e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—PPARG—metabolic syndrome X	4.43e-06	2.02e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—INS—metabolic syndrome X	4.35e-06	1.98e-05	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism—AKT1—metabolic syndrome X	4.01e-06	1.83e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—ALB—metabolic syndrome X	3.98e-06	1.82e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—NOS3—metabolic syndrome X	3.81e-06	1.74e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—PTGS2—metabolic syndrome X	3.49e-06	1.59e-05	CbGpPWpGaD
Celecoxib—ALB—Metabolism—AKT1—metabolic syndrome X	3.25e-06	1.48e-05	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—AKT1—metabolic syndrome X	2.68e-06	1.22e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—AKT1—metabolic syndrome X	2.66e-06	1.21e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—AKT1—metabolic syndrome X	1.75e-06	7.99e-06	CbGpPWpGaD
